Target intelligence / Profile preview

10 kDa culture filtrate antigen CFP-10 (CFP-10)

Target
CFP-10
Molecular classification
Secreted protein, Virulence factor, Antigen, WXG100 family protein
01

Overview

10 kDa culture filtrate antigen CFP-10 (also known as EsxB) is a low-molecular-weight protein secreted by Mycobacterium tuberculosis that is essential for its virulence [2, 8]. It forms a stable 1:1 heterodimeric complex with the early secreted antigenic target 6 (ESAT-6), which is secreted via the Type VII secretion system (ESX-1) [2, 10]. This complex facilitates the escape of the pathogen from the host macrophage's phagosome into the cytoplasm, a critical step for bacterial survival and replication [12, 16]. CFP-10 also modulates host immune responses by inhibiting reactive oxygen species (ROS) production, suppressing autophagy, and activating neutrophils through a G-protein-coupled receptor [8, 9, 14]. In clinical applications, CFP-10 is a major T-cell antigen used in interferon-gamma release assays (IGRAs) to diagnose tuberculosis infection, as it is absent in the BCG vaccine strain [1, 3, 17]. While no small-molecule drugs currently target CFP-10, it is a key component in several experimental vaccines, such as the live-attenuated MTBVAC and the subunit vaccine H56:IC31 [11, 17]. Research is ongoing into anti-virulence therapies that aim to disrupt the ESAT-6/CFP-10 complex or its secretion to attenuate the pathogen's ability to subvert host defenses [12].

Other names
EsxBMTSA-10Mycobacterium tuberculosis-specific antigen 10L-ESAT-6-like protein esxBRv3874
02

Mechanism of action

Vaccine antigen for induction of cellular immune response; diagnostic antigen for interferon-gamma release assays.

03

Biological functions

VirulenceImmune modulationPhagosomal escapeNeutrophil activationInhibition of autophagyInhibition of ROS production
04

Disease associations

Infection
05

Safety considerations

Cross-reactivity with non-tuberculous mycobacteria (e.g., M. kansasii, M. marinum, M. szulgai)Potential for immune-mediated side effects in vaccine applicationsDiagnostic interference in specific populations
06

Interacting drugs

MTBVAC

2 more in the full profile.

07

Biomarkers

Interferon-gamma (IFN-γ)CFP-10 peptide (serum/urine)

Beyond the preview

Go deeper on 10 kDa culture filtrate antigen CFP-10 (CFP-10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 10 kDa culture filtrate antigen CFP-10 (CFP-10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call